APP and early-onset autosomal dominant Alzheimer disease: In addition, while our study demonstrates that DSS and its disassembled prescriptions ameliorate Alzheimer’s disease-associated cognitive deficits and gut dysbiosis in APP/PS1 mice, we acknowledge a critical limitation highlighted by recent metaproteomic evidence.